Abstract
Background and objectives
Hereditary spastic paraplegias (HSPs) are heterogenous genetic disorders characterized by progressive pyramidal tract involvement. SPG76 is a recently identified form of HSP, caused by biallelic calpain-1 (CAPN1) variants. The most frequently described MRI abnormality in SPG76 is mild cerebellar atrophy and non-specific white matter abnormalities were reported in only one case. Following the identification of prominent white matter abnormalities in a subject with CAPN1 variants, which delayed the diagnosis, we aimed to verify the presence of MRI patterns of white matter involvement specific to this HSP.
Methods
We performed a retrospective radiological qualitative analysis of 15 subjects with SPG76 (4 previously unreported) initially screened for white matter involvement. Moreover, we performed quantitative analyses in our proband with available longitudinal studies.
Results
We observed bilateral, periventricular white matter involvement in 12 subjects (80%), associated with multifocal subcortical abnormalities in 5 of them (33.3%). Three subjects (20%) presented only multifocal subcortical involvement. Longitudinal quantitative analyses of our proband revealed increase in multifocal white matter lesion count and increased area of periventricular white matter involvement over time.
Discussion
SPG76 should be added to the list of HSPs with associated white matter abnormalities. We identified periventricular white matter involvement in subjects with SPG76, variably associated with multifocal subcortical white matter abnormalities. These findings, in the presence of progressive spastic paraparesis, can mislead the diagnostic process towards an acquired white matter disorder.
Similar content being viewed by others
Data availability
Anonymized data will be shared upon reasonable request from the corresponding author.
References
Mackay-Sim A (2021) Hereditary spastic paraplegia: from genes, cells and networks to novel pathways for drug discovery. Brain Sci 11:403
Hirst J, Madeo M, Smets K, Edgar JR, Schols L, Li J, Yarrow A, Deconinck T, Baets J, Van Aken E, De Bleecker J, Datiles MB 3rd, Roda RH, Liepert J, Zuchner S, Mariotti C, De Jonghe P, Blackstone C, Kruer MC (2016) Complicated spastic paraplegia in patients with AP5Z1 mutations (SPG48). Neurol Genet 2:e98
Martin E, Schüle R, Smets K, Rastetter A, Boukhris A, Loureiro JL, Gonzalez MA, Mundwiller E, Deconinck T, Wessner M (2013) Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia. Am J Hum Genet 92:238–244
Hammer MB, Eleuch-Fayache G, Schottlaender LV, Nehdi H, Gibbs JR, Arepalli SK, Chong SB, Hernandez DG, Sailer A, Liu G, Mistry PK, Cai H, Shrader G, Sassi C, Bouhlal Y, Houlden H, Hentati F, Amouri R, Singleton AB (2013) Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with spasticity. Am J Hum Genet 92:245–251
Shribman S, Reid E, Crosby AH, Houlden H, Warner TT (2019) Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches. Lancet Neurol 18:1136–1146
Giannoccaro MP, Matteo E, Bartiromo F, Tonon C, Santorelli FM, Liguori R, Rizzo G (2022) Multiple sclerosis in patients with hereditary spastic paraplegia: a case report and systematic review. Neurol Sci 43:5501–5511
Mukai M, Koh K, Ohnuki Y, Nagata E, Takiyama Y, Takizawa S (2018) Novel SPG11 mutations in a patient with symptoms mimicking multiple sclerosis. Intern Med 57:3183–3186
Romagnolo A, Masera S, Mattioda A, Superti G, Santorelli FM, Mongini T, Pinessi L, Cavalla P (2014) Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation. Eur J Neurol 21:e14-15
Rubegni A, Battisti C, Tessa A, Cerase A, Doccini S, Malandrini A, Santorelli FM, Federico A (2017) SPG2 mimicking multiple sclerosis in a family identified using next generation sequencing. J Neurol Sci 375:198–202
Gan-Or Z, Bouslam N, Birouk N, Lissouba A, Chambers DB, Veriepe J, Androschuk A, Laurent SB, Rochefort D, Spiegelman D, Dionne-Laporte A, Szuto A, Liao M, Figlewicz DA, Bouhouche A, Benomar A, Yahyaoui M, Ouazzani R, Yoon G, Dupre N, Suchowersky O, Bolduc FV, Parker JA, Dion PA, Drapeau P, Rouleau GA, Ouled Amar Bencheikh B (2016) Mutations in CAPN1 cause autosomal-recessive hereditary spastic paraplegia. Am J Hum Genet 98:1038–1046
Wang Y, Liu Y, Bi X, Baudry M (2020) Calpain-1 and calpain-2 in the brain: new evidence for a critical role of calpain-2 in neuronal death. Cells. 9(12):2698
Goizet C, Boukhris A, Durr A, Beetz C, Truchetto J, Tesson C, Tsaousidou M, Forlani S, Guyant-Marechal L, Fontaine B, Guimaraes J, Isidor B, Chazouilleres O, Wendum D, Grid D, Chevy F, Chinnery PF, Coutinho P, Azulay JP, Feki I, Mochel F, Wolf C, Mhiri C, Crosby A, Brice A, Stevanin G (2009) CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5. Brain 132:1589–1600
Biancheri R, Ciccolella M, Rossi A, Tessa A, Cassandrini D, Minetti C, Santorelli FM (2009) White matter lesions in spastic paraplegia with mutations in SPG5/CYP7B1. Neuromuscul Disord 19:62–65
Rahimi Bidgoli MM, Javanparast L, Rohani M, Najmabadi H, Zamani B, Alavi A (2021) CAPN1 and hereditary spastic paraplegia: a novel variant in an Iranian family and overview of the genotype-phenotype correlation. Int J Neurosci 131:962–974
Shetty A, Gan-Or Z, Ashtiani S, Ruskey JA, van de Warrenburg B, Wassenberg T, Kamsteeg EJ, Rouleau GA, Suchowersky O (2019) CAPN1 mutations: expanding the CAPN1-related phenotype: from hereditary spastic paraparesis to spastic ataxia. Eur J Med Genet 62:103605
Wang Y, Hersheson J, Lopez D, Hammer M, Liu Y, Lee KH, Pinto V, Seinfeld J, Wiethoff S, Sun J, Amouri R, Hentati F, Baudry N, Tran J, Singleton AB, Coutelier M, Brice A, Stevanin G, Durr A, Bi X, Houlden H, Baudry M (2016) Defects in the CAPN1 gene result in alterations in cerebellar development and cerebellar ataxia in mice and humans. Cell Rep 16:79–91
Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, Gerig G (2006) User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 31:1116–1128
Vrij-Van Den Bos S, Hol JA, La Piana R, Harting I, Vanderver A, Barkhof F, Cayami F, Van Wieringen WN, Pouwels PJ, Van Der Knaap MS (2017) 4H leukodystrophy: a brain magnetic resonance imaging scoring system. Neuropediatrics 48:152–160
Criscuolo C, Carbone R, Lieto M, Peluso S, Guacci A, Filla A, Quarantelli M, Lanzillo R, Morra VB, De Michele G (2016) SPG5 and multiple sclerosis: clinical and genetic overlap? Acta Neurol Scand 133:410–414
Neema M, Guss ZD, Stankiewicz JM, Arora A, Healy BC, Bakshi R (2009) Normal findings on brain fluid-attenuated inversion recovery MR images at 3T. AJNR Am J Neuroradiol 30:911–916
Goizet C, Boukhris A, Maltete D, Guyant-Marechal L, Truchetto J, Mundwiller E, Hanein S, Jonveaux P, Roelens F, Loureiro J, Godet E, Forlani S, Melki J, Auer-Grumbach M, Fernandez JC, Martin-Hardy P, Sibon I, Sole G, Orignac I, Mhiri C, Coutinho P, Durr A, Brice A, Stevanin G (2009) SPG15 is the second most common cause of hereditary spastic paraplegia with thin corpus callosum. Neurology 73:1111–1119
Filippi M, Preziosa P, Banwell BL, Barkhof F, Ciccarelli O, De Stefano N, Geurts JJG, Paul F, Reich DS, Toosy AT, Traboulsee A, Wattjes MP, Yousry TA, Gass A, Lubetzki C, Weinshenker BG, Rocca MA (2019) Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain 142:1858–1875
Méreaux JL, Firanescu C, Coarelli G, Kvarnung M, Rodrigues R, Pegoraro E, Tazir M, Taithe F, Valter R, Huin V, Lidström K, Banneau G, Morais S, Parodi L, Coutelier M, Papin M, Svenningsson P, Azulay JP, Alonso I, Nilsson D, Brice A, Le Guern E, Press R, Vazza G, Loureiro JL, Goizet C, Durr A, Paucar M, Stevanin G (2021) Increasing involvement of CAPN1 variants in spastic ataxias and phenotype-genotype correlations. Neurogenetics 22:71–79
Souza PVS, Silva LHL, Badia BML, Farias IB, Pinto W, Oliveira ASB (2019) SPG76: an extremely rare hereditary spastic paraplegia with a new expanding complicated phenotype. Rev Neurol (Paris) 175:572–574
Travaglini L, Bellacchio E, Aiello C, Pro S, Bertini E, Nicita F (2017) Expanding the clinical phenotype of CAPN1-associated mutations: a new case with congenital-onset pure spastic paraplegia. J Neurol Sci 378:210–212
Cotti Piccinelli S, Bassi MT, Citterio A, Manganelli F, Tozza S, Santorelli FM, Gallo Cassarino S, Caria F, Baldelli E, Galvagni A, Santoro L, Padovani A, Filosto M (2019) A novel CAPN1 mutation causes a pure hereditary spastic paraplegia in an italian family. Front Neurol 10:580
Kocoglu C, Gundogdu A, Kocaman G, Kahraman-Koytak P, Uluc K, Kiziltan G, Caglayan AO, Bilguvar K, Vural A, Basak AN (2018) Homozygous CAPN1 mutations causing a spastic-ataxia phenotype in 2 families. Neurol Genet 4:e218
Peng F, Sun YM, Quan C, Wang J, Wu JJ (2019) Two novel homozygous mutations of CAPN1 in Chinese patients with hereditary spastic paraplegia and literatures review. Orphanet J Rare Dis 14:83
Funding
R. La Piana has received a Research Scholar Junior 1 award from the Fonds de Recherche du Québec en Santé (FRQS), research funds from the Canadian Radiological Foundation and from the Spastic Paraplegia Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
A. Alkhalifa reports no disclosures relevant to the manuscript. S. Chen reports no disclosures relevant to the manuscript. Z. I. Hasiloglu reports no disclosures relevant to the manuscript. M. Filosto reports no disclosures relevant to the manuscript. E. Cali reports no disclosures relevant to the manuscript. H. Houlden reports no disclosures relevant to the manuscript. P.V.S. de Souza reports no disclosures relevant to the manuscript. A. Alavi reports no disclosures relevant to the manuscript. C. Goizet reports no disclosures relevant to the manuscript. G. Stevanin reports a Biogen-Paris-Sciences Lettres contract unrelated to this work, and a grant support from the ASL-HSP-France Association (to GS) related to genetic studies in HSP patients. F. Taithe reports no disclosures relevant to the manuscript. F. Nicita is a member of the European Reference Network for Rare Neurological Diseases (ERN-RND). G. Vasco reports no disclosures relevant to the manuscript. S. Tozza has received personal fees for scientific events from Alnylam Pharmaceuticals and Amicus Therapeutics, travel grants to attend scientific meetings from Akcea Therapeutics. S. Cocozza has received research grants from Telethon and FISM, and fees for speaking from Amicus Therapeutics. N. Carboni reports no disclosures relevant to the manuscript. A. Figus reports no disclosures relevant to the manuscript. J. Wu reports no disclosures relevant to the manuscript. A. N. Basak reports no disclosures relevant to the manuscript. B. Brais reports no disclosures relevant to the manuscript. G. Rouleau reports no disclosures relevant to the manuscript.
Ethical standard
The Institutional Review Boards of the participating institutions have approved the use of data for this retrospective study.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Alkhalifa, A., Chen, S., Hasiloglu, Z.I. et al. White matter abnormalities in 15 subjects with SPG76. J Neurol 270, 5784–5792 (2023). https://doi.org/10.1007/s00415-023-11918-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-023-11918-5